Skip to main content

Cell biology startup Transition Bio hires first CEO

Nearly a year after publicly launching, Transition Bio has its first CEO in Gregory Miller, who was the second employee at another local startup, neurodegenerative disease-focused Atalanta Therapeutics.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.